Greatbatch (GB) 30.93 $GB
Greatbatch (GB) Misses on Q1 Earnings & Sales, View Intact
Zacks Equity Research - Zacks Investment Research - Thu May 05, 8:27AM CDT
Greatbatch Inc. (GB) reported adjusted earnings of 34 cents per share in the first quarter of 2016, which plunged 47.7% from the year-ago quarter.
IRMD: 20.85 (-0.63), GB: 30.93 (+0.63), NVTR: 7.21 (-0.10), EW: 106.72 (+0.45)
Greatbatch reports 1Q loss
Automated Insights - Thu Apr 28, 5:21PM CDT
FRISCO, Texas (AP) _ Greatbatch Inc. (GB) on Thursday reported a first-quarter loss of $12.7 million, after reporting a profit in the same period a year earlier.
GB: 30.93 (+0.63)
Greatbatch, Inc. Reports 2016 First Quarter Results
GlobeNewswire - Thu Apr 28, 3:06PM CDT
Greatbatch, Inc. (NYSE:GB), today announced results for its first quarter ended April 1, 2016.
GB: 30.93 (+0.63), NVTR: 7.21 (-0.10)
Oxford Finance and Silicon Valley Bank Close $45 Million Credit Facility with Nuvectra
PR Newswire - Thu Apr 21, 12:00PM CDT
Oxford Finance LLC ("Oxford"
, a specialty finance firm that provides senior debt to life sciences and healthcare services companies, and Silicon Valley Bank, the bank of the world's most innovative companies and their investors, today announced the closing of a $45 million term loan to Nuvectra Corporation ("the Company" or "Nuvectra". The facility is comprised of a $40 million senior secured term loan and a $5 million line of credit. Funds are being used to finance the Company's recent spin-off from its parent company, Greatbatch, Inc., and to establish a market presence in the United States for its first product, Algovita®.
GB: 30.93 (+0.63), NVTR: 7.21 (-0.10)
Greatbatch, Inc. to Host Q1 2016 Earnings Conference Call Thursday, April 28, 2016 at 5:00 p.m. Eastern
GlobeNewswire - Tue Apr 12, 4:04PM CDT
Greatbatch, Inc. (NYSE:GB) announced today that it will host the 1 quarter 2016 earnings conference call on Thursday, April 28, 2016 at 5:00 p.m. Eastern Time to discuss the operating results for the first quarter ended April 1, 2016. A press release will be issued after the market closes on that day.
GB: 30.93 (+0.63)
Greatbatch Completes QiG Spin-Off; Nuvectra Begins Trading
Zacks Equity Research - Zacks Investment Research - Tue Mar 15, 12:10PM CDT
Greatbatch (GB) recently announced the completion of the spin-off of its subsidiary, QiG Group.
ABMD: 117.98 (+0.22), GB: 30.93 (+0.63), LMNX: 22.30 (+0.03), CRY: 12.28 (+0.08)
Nuvectra Corporation Begins Trading on NASDAQ
GlobeNewswire - Mon Mar 14, 6:17PM CDT
Nuvectra Corporation (NASDAQ:NVTR), formerly QIG Group, LLC, announced today the completion of its spin-off from Greatbatch, Inc. (NYSE:GB) into an independent, publicly-traded neurostimulation medical device company. Nuvectra shares commenced "regular way" trading today on the NASDAQ Global Market (NASDAQ) under the symbol "NVTR".
GB: 30.93 (+0.63), NVTR: 7.21 (-0.10)
Greatbatch (GB) Lifts Q1 and FY16 Guidance, Shares Rally
Zacks Equity Research - Zacks Investment Research - Tue Mar 08, 12:10PM CST
Shares of Greatbatch Inc. (GB) surged 5.3% to close at $36.64 on Mar 8, after the company updated its first-quarter and full-year 2016 guidance.
ABMD: 117.98 (+0.22), GB: 30.93 (+0.63), EW: 106.72 (+0.45), CRY: 12.28 (+0.08)
Greatbatch (GB) Looks Good: Stock Moves 5.3% Higher
Zacks Equity Research - Zacks Investment Research - Tue Mar 08, 7:00AM CST
Greatbatch (GB) was a big mover last session, with its shares rising over 5% on the day.
GB: 30.93 (+0.63), CREE: 25.11 (-0.12)
Greatbatch, Inc. Updated Guidance 2016
GlobeNewswire - Mon Mar 07, 7:00AM CST
Greatbatch, Inc. (NYSE:GB), announced today that it has updated guidance for 2016.
GB: 30.93 (+0.63)
Greatbatch Has Returned 30.3% Since SmarTrend Recommendation (GB)
Comtex SmarTrend(R) - Wed Feb 03, 6:18PM CST
SmarTrend identified a Downtrend for Greatbatch (NYSE:GB) on December 21st, 2015 at $53.63. In approximately 1 month, Greatbatch has returned 30.32% as of today's recent price of $37.37.
GB: 30.93 (+0.63)
Aleva Neurotherapeutics and Greatbatch Collaborate on Next-Generation Device for Deep Brain Stimulation (DBS)
GlobeNewswire - Mon Feb 01, 3:29PM CST
Aleva Neurotherapeutics, a leading company developing next-generation implants for deep brain stimulation (DBS) in major neurological indications such as Parkinson's disease and essential tremor, today announced a strategic development, supply, and manufacturing relationship with Greatbatch Ltd., a subsidiary of Greatbatch, Inc. (NYSE:GB). In addition, Greatbatch will invest in Aleva Neurotherapeutics' current Series C financing round.
GB: 30.93 (+0.63)
Greatbatch (GB) Wins Patent Suit, Gets $35.7M in Damages
Zacks Equity Research - Zacks Investment Research - Wed Jan 27, 2:10PM CST
Greatbatch Inc. (GB) recently won favorable verdict in a patent infringement lawsuit against AVX Corporation and AVX Filters Corporation.
STAA: 6.26 (+0.02), GB: 30.93 (+0.63), EXAC: 27.78 (+0.23), VASC: 43.30 (-0.46)
AVX Corporation Announces Jury Verdict in Intellectual Property Lawsuit
BusinessWire - Wed Jan 27, 7:30AM CST
AVX Corporation (NYSE: AVX) today reported a jury verdict in a patent infringement case filed in the United States District Court for the District of Delaware captioned Greatbatch, Inc. v AVX Corporation.
GB: 30.93 (+0.63), AVX: 13.88 (-0.01)
Greatbatch Awarded $37.5 Million in Patent Infringement Lawsuit Against AVX Corporation
GlobeNewswire - Tue Jan 26, 4:33PM CST
Greatbatch Inc., (NYSE:GB) today announced that a jury in the United States District Court for the District of Delaware returned a verdict finding that AVX Corporation and AVX Filters Corporation infringed two Greatbatch patents, and in the process awarded Greatbatch $37.5 million in damages. The complaint, filed in April 2013, alleged that AVX had infringed Greatbatch patents by manufacturing and selling filtered feedthrough assemblies used in implantable pacemakers and cardioverter defibrillators that incorporate its patented technology.
GB: 30.93 (+0.63), AVX: 13.88 (-0.01)
Bernard Bailey Appointed Chairman and Steve Odland Joins Analogic's Board
GlobeNewswire - Tue Jan 26, 2:17PM CST
Analogic Corporation (Nasdaq:ALOG), enabling the world's medical imaging and aviation security technology, announced today that Bernard Bailey, chief executive officer and chairman of Authentix, Inc., has been appointed chairman of the board. Mr. Bailey succeeds Ed Voboril, former chairman and chief executive officer of Greatbatch, Inc. Mr. Voboril, who served as Analogic's chairman since 2008 and as a director since 1990, did not stand for re-election as a director in view of the Company's director retirement policy. In addition, Steve Odland, president and chief executive officer of the Committee for Economic Development, has been elected to the board to fill the vacancy created by Mr. Voboril's retirement. The appointment of Mr. Bailey and election of Mr. Odland were confirmed at the Company's board of directors meeting held on Thursday, January 21, 2016.
ALOG: 81.93 (-0.22), GB: 30.93 (+0.63)
Shares of GB Down 25.1% Since Downtrend Call on Shares
Comtex SmarTrend(R) - Wed Jan 20, 11:12AM CST
SmarTrend identified a Downtrend for Greatbatch (NYSE:GB) on December 21st, 2015 at $53.63. In approximately 1 month, Greatbatch has returned 25.12% as of today's recent price of $40.16.
GB: 30.93 (+0.63)
The Zacks Analyst Blog Highlights: Intel, NVIDIA, Greatbatch, M/A-Com Technology Solutions Holdings and MaxLinear
Zacks Equity Research - Zacks Investment Research - Wed Jan 20, 8:30AM CST
The Zacks Analyst Blog Highlights: Intel, NVIDIA, Greatbatch, M/A-Com Technology Solutions Holdings and MaxLinear
MTSI: 35.02 (+0.21), GB: 30.93 (+0.63), MXL: 20.57 (-0.15), INTC: 35.11 (+0.17), NVDA: 52.99 (+0.19)
Greatbatch Down 17.9% Since SmarTrend Downtrend Call (GB)
Comtex SmarTrend(R) - Wed Jan 13, 10:20AM CST
SmarTrend identified a Downtrend for Greatbatch (NYSE:GB) on December 21st, 2015 at $53.63. In approximately 3 weeks, Greatbatch has returned 17.88% as of today's recent price of $44.04.
GB: 30.93 (+0.63)
Greatbatch Unveils 2015 Preliminary Results & 2016 Outlook
Zacks Equity Research - Zacks Investment Research - Tue Jan 12, 1:45PM CST
Greatbatch (GB) recently announced preliminary results for 2015 and unveiled the outlook for 2016.
DXCM: 79.66 (-0.14), GB: 30.93 (+0.63), EXAC: 27.78 (+0.23), FMS: 43.93 (+0.31)
Greatbatch (GB) Misses on Q1 Earnings & Sales, View Intact
Zacks Equity Research - Zacks Investment Research - Thu May 05, 8:27AM CDT
Greatbatch Inc. (GB) reported adjusted earnings of 34 cents per share in the first quarter of 2016, which plunged 47.7% from the year-ago quarter.
IRMD: 20.85 (-0.63), GB: 30.93 (+0.63), NVTR: 7.21 (-0.10), EW: 106.72 (+0.45)
Greatbatch reports 1Q loss
Automated Insights - Thu Apr 28, 5:21PM CDT
FRISCO, Texas (AP) _ Greatbatch Inc. (GB) on Thursday reported a first-quarter loss of $12.7 million, after reporting a profit in the same period a year earlier.
GB: 30.93 (+0.63)
Greatbatch, Inc. Reports 2016 First Quarter Results
GlobeNewswire - Thu Apr 28, 3:06PM CDT
Greatbatch, Inc. (NYSE:GB), today announced results for its first quarter ended April 1, 2016.
GB: 30.93 (+0.63), NVTR: 7.21 (-0.10)
Oxford Finance and Silicon Valley Bank Close $45 Million Credit Facility with Nuvectra
PR Newswire - Thu Apr 21, 12:00PM CDT
Oxford Finance LLC ("Oxford"
, a specialty finance firm that provides senior debt to life sciences and healthcare services companies, and Silicon Valley Bank, the bank of the world's most innovative companies and their investors, today announced the closing of a $45 million term loan to Nuvectra Corporation ("the Company" or "Nuvectra". The facility is comprised of a $40 million senior secured term loan and a $5 million line of credit. Funds are being used to finance the Company's recent spin-off from its parent company, Greatbatch, Inc., and to establish a market presence in the United States for its first product, Algovita®. GB: 30.93 (+0.63), NVTR: 7.21 (-0.10)
Greatbatch, Inc. to Host Q1 2016 Earnings Conference Call Thursday, April 28, 2016 at 5:00 p.m. Eastern
GlobeNewswire - Tue Apr 12, 4:04PM CDT
Greatbatch, Inc. (NYSE:GB) announced today that it will host the 1 quarter 2016 earnings conference call on Thursday, April 28, 2016 at 5:00 p.m. Eastern Time to discuss the operating results for the first quarter ended April 1, 2016. A press release will be issued after the market closes on that day.
GB: 30.93 (+0.63)
Greatbatch Completes QiG Spin-Off; Nuvectra Begins Trading
Zacks Equity Research - Zacks Investment Research - Tue Mar 15, 12:10PM CDT
Greatbatch (GB) recently announced the completion of the spin-off of its subsidiary, QiG Group.
ABMD: 117.98 (+0.22), GB: 30.93 (+0.63), LMNX: 22.30 (+0.03), CRY: 12.28 (+0.08)
Nuvectra Corporation Begins Trading on NASDAQ
GlobeNewswire - Mon Mar 14, 6:17PM CDT
Nuvectra Corporation (NASDAQ:NVTR), formerly QIG Group, LLC, announced today the completion of its spin-off from Greatbatch, Inc. (NYSE:GB) into an independent, publicly-traded neurostimulation medical device company. Nuvectra shares commenced "regular way" trading today on the NASDAQ Global Market (NASDAQ) under the symbol "NVTR".
GB: 30.93 (+0.63), NVTR: 7.21 (-0.10)
Greatbatch (GB) Lifts Q1 and FY16 Guidance, Shares Rally
Zacks Equity Research - Zacks Investment Research - Tue Mar 08, 12:10PM CST
Shares of Greatbatch Inc. (GB) surged 5.3% to close at $36.64 on Mar 8, after the company updated its first-quarter and full-year 2016 guidance.
ABMD: 117.98 (+0.22), GB: 30.93 (+0.63), EW: 106.72 (+0.45), CRY: 12.28 (+0.08)
Greatbatch (GB) Looks Good: Stock Moves 5.3% Higher
Zacks Equity Research - Zacks Investment Research - Tue Mar 08, 7:00AM CST
Greatbatch (GB) was a big mover last session, with its shares rising over 5% on the day.
GB: 30.93 (+0.63), CREE: 25.11 (-0.12)
Greatbatch, Inc. Updated Guidance 2016
GlobeNewswire - Mon Mar 07, 7:00AM CST
Greatbatch, Inc. (NYSE:GB), announced today that it has updated guidance for 2016.
GB: 30.93 (+0.63)
Greatbatch Has Returned 30.3% Since SmarTrend Recommendation (GB)
Comtex SmarTrend(R) - Wed Feb 03, 6:18PM CST
SmarTrend identified a Downtrend for Greatbatch (NYSE:GB) on December 21st, 2015 at $53.63. In approximately 1 month, Greatbatch has returned 30.32% as of today's recent price of $37.37.
GB: 30.93 (+0.63)
Aleva Neurotherapeutics and Greatbatch Collaborate on Next-Generation Device for Deep Brain Stimulation (DBS)
GlobeNewswire - Mon Feb 01, 3:29PM CST
Aleva Neurotherapeutics, a leading company developing next-generation implants for deep brain stimulation (DBS) in major neurological indications such as Parkinson's disease and essential tremor, today announced a strategic development, supply, and manufacturing relationship with Greatbatch Ltd., a subsidiary of Greatbatch, Inc. (NYSE:GB). In addition, Greatbatch will invest in Aleva Neurotherapeutics' current Series C financing round.
GB: 30.93 (+0.63)
Greatbatch (GB) Wins Patent Suit, Gets $35.7M in Damages
Zacks Equity Research - Zacks Investment Research - Wed Jan 27, 2:10PM CST
Greatbatch Inc. (GB) recently won favorable verdict in a patent infringement lawsuit against AVX Corporation and AVX Filters Corporation.
STAA: 6.26 (+0.02), GB: 30.93 (+0.63), EXAC: 27.78 (+0.23), VASC: 43.30 (-0.46)
AVX Corporation Announces Jury Verdict in Intellectual Property Lawsuit
BusinessWire - Wed Jan 27, 7:30AM CST
AVX Corporation (NYSE: AVX) today reported a jury verdict in a patent infringement case filed in the United States District Court for the District of Delaware captioned Greatbatch, Inc. v AVX Corporation.
GB: 30.93 (+0.63), AVX: 13.88 (-0.01)
Greatbatch Awarded $37.5 Million in Patent Infringement Lawsuit Against AVX Corporation
GlobeNewswire - Tue Jan 26, 4:33PM CST
Greatbatch Inc., (NYSE:GB) today announced that a jury in the United States District Court for the District of Delaware returned a verdict finding that AVX Corporation and AVX Filters Corporation infringed two Greatbatch patents, and in the process awarded Greatbatch $37.5 million in damages. The complaint, filed in April 2013, alleged that AVX had infringed Greatbatch patents by manufacturing and selling filtered feedthrough assemblies used in implantable pacemakers and cardioverter defibrillators that incorporate its patented technology.
GB: 30.93 (+0.63), AVX: 13.88 (-0.01)
Bernard Bailey Appointed Chairman and Steve Odland Joins Analogic's Board
GlobeNewswire - Tue Jan 26, 2:17PM CST
Analogic Corporation (Nasdaq:ALOG), enabling the world's medical imaging and aviation security technology, announced today that Bernard Bailey, chief executive officer and chairman of Authentix, Inc., has been appointed chairman of the board. Mr. Bailey succeeds Ed Voboril, former chairman and chief executive officer of Greatbatch, Inc. Mr. Voboril, who served as Analogic's chairman since 2008 and as a director since 1990, did not stand for re-election as a director in view of the Company's director retirement policy. In addition, Steve Odland, president and chief executive officer of the Committee for Economic Development, has been elected to the board to fill the vacancy created by Mr. Voboril's retirement. The appointment of Mr. Bailey and election of Mr. Odland were confirmed at the Company's board of directors meeting held on Thursday, January 21, 2016.
ALOG: 81.93 (-0.22), GB: 30.93 (+0.63)
Shares of GB Down 25.1% Since Downtrend Call on Shares
Comtex SmarTrend(R) - Wed Jan 20, 11:12AM CST
SmarTrend identified a Downtrend for Greatbatch (NYSE:GB) on December 21st, 2015 at $53.63. In approximately 1 month, Greatbatch has returned 25.12% as of today's recent price of $40.16.
GB: 30.93 (+0.63)
The Zacks Analyst Blog Highlights: Intel, NVIDIA, Greatbatch, M/A-Com Technology Solutions Holdings and MaxLinear
Zacks Equity Research - Zacks Investment Research - Wed Jan 20, 8:30AM CST
The Zacks Analyst Blog Highlights: Intel, NVIDIA, Greatbatch, M/A-Com Technology Solutions Holdings and MaxLinear
MTSI: 35.02 (+0.21), GB: 30.93 (+0.63), MXL: 20.57 (-0.15), INTC: 35.11 (+0.17), NVDA: 52.99 (+0.19)
Greatbatch Down 17.9% Since SmarTrend Downtrend Call (GB)
Comtex SmarTrend(R) - Wed Jan 13, 10:20AM CST
SmarTrend identified a Downtrend for Greatbatch (NYSE:GB) on December 21st, 2015 at $53.63. In approximately 3 weeks, Greatbatch has returned 17.88% as of today's recent price of $44.04.
GB: 30.93 (+0.63)
Greatbatch Unveils 2015 Preliminary Results & 2016 Outlook
Zacks Equity Research - Zacks Investment Research - Tue Jan 12, 1:45PM CST
Greatbatch (GB) recently announced preliminary results for 2015 and unveiled the outlook for 2016.
DXCM: 79.66 (-0.14), GB: 30.93 (+0.63), EXAC: 27.78 (+0.23), FMS: 43.93 (+0.31)
